Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: Clinical and instrumental evaluation

Enzo Berardesca, Norma Cameli, Claudia Cavallotti, Jean Luc Levy, Gérald E. Piérard, Gianfranco De Paoli Ambrosi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objective: This study aims to evaluate a topical treatment based on silymarin/methylsulfonilmethane (S-MSM) to improve erythematous-telangiectactic rosacea. Methods: Forty-six patients affected by stage I-III rosacea entered this double-blind, placebo-controlled study. Subjects were treated for 1 month. Clinical and instrumental evaluations were done at baseline, after 10 and 20 days, and at the end of the study. Itching, stinging, erythema, and papules were investigated clinically as well as hydration and erythema instrumentally with capacitance and color measurements. Results: A statistically significant improvement was observed in many clinical and instrumental parameters investigated (P <0.001). In particular, improvement of skin redness, papules, itching, hydration, and skin color occurred. Conclusions: The combination of silymarin and S-MSM can be useful in managing symptoms and condition of rosacea skin, especially in the rosacea subtype 1 erythemato-telangiectatic phase. The action can be considered multicentric and multiphase because of the direct modulating action on cytokines and angiokines normally involved and up-regulated in the case of such skin condition.

Original languageEnglish
Pages (from-to)8-14
Number of pages7
JournalJournal of Cosmetic Dermatology
Volume7
Issue number1
DOIs
Publication statusPublished - Mar 2008

Fingerprint

Silymarin
Rosacea
Erythema
Pruritus
Skin
Skin Pigmentation
Color
Placebos
Cytokines
dimethyl sulfone

Keywords

  • Acne rosacea
  • Erythema
  • Telangiectases

ASJC Scopus subject areas

  • Dermatology

Cite this

Combined effects of silymarin and methylsulfonylmethane in the management of rosacea : Clinical and instrumental evaluation. / Berardesca, Enzo; Cameli, Norma; Cavallotti, Claudia; Levy, Jean Luc; Piérard, Gérald E.; De Paoli Ambrosi, Gianfranco.

In: Journal of Cosmetic Dermatology, Vol. 7, No. 1, 03.2008, p. 8-14.

Research output: Contribution to journalArticle

Berardesca, Enzo ; Cameli, Norma ; Cavallotti, Claudia ; Levy, Jean Luc ; Piérard, Gérald E. ; De Paoli Ambrosi, Gianfranco. / Combined effects of silymarin and methylsulfonylmethane in the management of rosacea : Clinical and instrumental evaluation. In: Journal of Cosmetic Dermatology. 2008 ; Vol. 7, No. 1. pp. 8-14.
@article{0230ede0c4a245adb7b8ee0027818a31,
title = "Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: Clinical and instrumental evaluation",
abstract = "Objective: This study aims to evaluate a topical treatment based on silymarin/methylsulfonilmethane (S-MSM) to improve erythematous-telangiectactic rosacea. Methods: Forty-six patients affected by stage I-III rosacea entered this double-blind, placebo-controlled study. Subjects were treated for 1 month. Clinical and instrumental evaluations were done at baseline, after 10 and 20 days, and at the end of the study. Itching, stinging, erythema, and papules were investigated clinically as well as hydration and erythema instrumentally with capacitance and color measurements. Results: A statistically significant improvement was observed in many clinical and instrumental parameters investigated (P <0.001). In particular, improvement of skin redness, papules, itching, hydration, and skin color occurred. Conclusions: The combination of silymarin and S-MSM can be useful in managing symptoms and condition of rosacea skin, especially in the rosacea subtype 1 erythemato-telangiectatic phase. The action can be considered multicentric and multiphase because of the direct modulating action on cytokines and angiokines normally involved and up-regulated in the case of such skin condition.",
keywords = "Acne rosacea, Erythema, Telangiectases",
author = "Enzo Berardesca and Norma Cameli and Claudia Cavallotti and Levy, {Jean Luc} and Pi{\'e}rard, {G{\'e}rald E.} and {De Paoli Ambrosi}, Gianfranco",
year = "2008",
month = "3",
doi = "10.1111/j.1473-2165.2008.00355.x",
language = "English",
volume = "7",
pages = "8--14",
journal = "Journal of Cosmetic Dermatology",
issn = "1473-2130",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "1",

}

TY - JOUR

T1 - Combined effects of silymarin and methylsulfonylmethane in the management of rosacea

T2 - Clinical and instrumental evaluation

AU - Berardesca, Enzo

AU - Cameli, Norma

AU - Cavallotti, Claudia

AU - Levy, Jean Luc

AU - Piérard, Gérald E.

AU - De Paoli Ambrosi, Gianfranco

PY - 2008/3

Y1 - 2008/3

N2 - Objective: This study aims to evaluate a topical treatment based on silymarin/methylsulfonilmethane (S-MSM) to improve erythematous-telangiectactic rosacea. Methods: Forty-six patients affected by stage I-III rosacea entered this double-blind, placebo-controlled study. Subjects were treated for 1 month. Clinical and instrumental evaluations were done at baseline, after 10 and 20 days, and at the end of the study. Itching, stinging, erythema, and papules were investigated clinically as well as hydration and erythema instrumentally with capacitance and color measurements. Results: A statistically significant improvement was observed in many clinical and instrumental parameters investigated (P <0.001). In particular, improvement of skin redness, papules, itching, hydration, and skin color occurred. Conclusions: The combination of silymarin and S-MSM can be useful in managing symptoms and condition of rosacea skin, especially in the rosacea subtype 1 erythemato-telangiectatic phase. The action can be considered multicentric and multiphase because of the direct modulating action on cytokines and angiokines normally involved and up-regulated in the case of such skin condition.

AB - Objective: This study aims to evaluate a topical treatment based on silymarin/methylsulfonilmethane (S-MSM) to improve erythematous-telangiectactic rosacea. Methods: Forty-six patients affected by stage I-III rosacea entered this double-blind, placebo-controlled study. Subjects were treated for 1 month. Clinical and instrumental evaluations were done at baseline, after 10 and 20 days, and at the end of the study. Itching, stinging, erythema, and papules were investigated clinically as well as hydration and erythema instrumentally with capacitance and color measurements. Results: A statistically significant improvement was observed in many clinical and instrumental parameters investigated (P <0.001). In particular, improvement of skin redness, papules, itching, hydration, and skin color occurred. Conclusions: The combination of silymarin and S-MSM can be useful in managing symptoms and condition of rosacea skin, especially in the rosacea subtype 1 erythemato-telangiectatic phase. The action can be considered multicentric and multiphase because of the direct modulating action on cytokines and angiokines normally involved and up-regulated in the case of such skin condition.

KW - Acne rosacea

KW - Erythema

KW - Telangiectases

UR - http://www.scopus.com/inward/record.url?scp=38949159704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949159704&partnerID=8YFLogxK

U2 - 10.1111/j.1473-2165.2008.00355.x

DO - 10.1111/j.1473-2165.2008.00355.x

M3 - Article

C2 - 18254805

AN - SCOPUS:38949159704

VL - 7

SP - 8

EP - 14

JO - Journal of Cosmetic Dermatology

JF - Journal of Cosmetic Dermatology

SN - 1473-2130

IS - 1

ER -